Implant Sciences Sells QS-B220 Explosives Trace Detectors for use at 19 Airports
- QS-B220 becomes the adopted standard for explosives trace detection equipment at a number of major airports in Latin American country
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that its QS-B220 explosives trace detectors have been sold to a federal agency in charge of operating 19 airports in one Latin American country. The units will be used for checkpoint screening and air cargo screening.
"With this deployment, our QS-B220 has become the system of choice in explosives trace detection devices for these 19 airports. This is a major milestone for Implant Sciences and gives the Company a significant presence in the Latin American aviation security market," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones. "The QS-B220 was selected based on its favorable total cost of ownership, superior performance capabilities, and its regulatory certifications."
Business Environment and Investment Outlook for ISR Technologies
Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.
Source : Implant Sciences Corporation
Apr 15 - 16, 2015 - Oslo, Norway